Literature DB >> 16185453

[Analysis on clinical and epidemiological characteristics of 1032 patients with Dengue fever in Guangzhou].

Fu-chun Zhang1, Yan-qing Chen, Ye-cheng Lu, Jian Wang, Wan-shan Chen, Wen-xin Hong.   

Abstract

OBJECTIVE: To analyze the clinical and epidemiological characteristics of Dengue fever (DF) during the Dengue-1 epidemic in Guangzhou.
METHODS: Clinical and epidemiological data of 1032 patients with DF from May 2002 to November 2003 were retrospectively analyzed. Dengue virus were isolated by cell culture and typed by reverse transcriptase polymerase chain reaction (RT-PCR).
RESULTS: Age of the patients ranged from 55 days to 91 years old (average 34.7 +/- 13.2 years) with sex ratio 1.03:1. Incubation period ranged from 2 to 12 days with mean periods of 5.3 +/- 2.4 days. Most (45.0%) cases appeared in September and the epidemic last from July to November. Dengue outbreak had involved 675 cases in 26 common places. The common manifestations were seen as fever (100%), headache (90.9%), myalgia (68.4%), bone soreness (48.8%), fatigue (79.3%), skin rash (60.1%), positive tourniquet test (45.3%), leukopenia (63.3%) and thrombocytopenia (60.8%), respectively. Dengue virus was isolated from serum of 19 out of 54 patients' and identified as Dengue virus type 1. DNA sequence analyzes on rates of nucleotide homology were 97%, 97% and 98% compared with those of Dengue virus type 1 strain of DF outbreak in Cambodia, in 1997 and 1999 in China.
CONCLUSION: The epidemic of DF in Guangzhou in 2002/2003 was caused by Dengue virus type-1 with most patients showing classic type of the disease. Date suggested that change can happen from non-endemic to hypoendemic regions in Guangdong province.

Entities:  

Mesh:

Year:  2005        PMID: 16185453

Source DB:  PubMed          Journal:  Zhonghua Liu Xing Bing Xue Za Zhi        ISSN: 0254-6450


  8 in total

1.  Serotype 1-specific monoclonal antibody-based antigen capture immunoassay for detection of circulating nonstructural protein NS1: Implications for early diagnosis and serotyping of dengue virus infections.

Authors:  Hua Xu; Biao Di; Yu-xian Pan; Li-wen Qiu; Ya-di Wang; Wei Hao; Li-juan He; Kwok-yung Yuen; Xiao-yan Che
Journal:  J Clin Microbiol       Date:  2006-08       Impact factor: 5.948

Review 2.  Dengue--quo tu et quo vadis?

Authors:  Rubing Chen; Nikos Vasilakis
Journal:  Viruses       Date:  2011-09-01       Impact factor: 5.048

Review 3.  Tourniquet Test for Dengue Diagnosis: Systematic Review and Meta-analysis of Diagnostic Test Accuracy.

Authors:  Antonio Jose Grande; Hamish Reid; Emma Thomas; Charlie Foster; Thomas C Darton
Journal:  PLoS Negl Trop Dis       Date:  2016-08-03

4.  Spatiotemporal Risk of Bacillary Dysentery and Sensitivity to Meteorological Factors in Hunan Province, China.

Authors:  Chengdong Xu; Gexin Xiao; Jinfeng Wang; Xiangxue Zhang; Jinjun Liang
Journal:  Int J Environ Res Public Health       Date:  2017-12-29       Impact factor: 3.390

5.  Interplay between environment, agriculture and infectious diseases of poverty: case studies in China.

Authors:  Guo-Jing Yang; Jürg Utzinger; Xiao-Nong Zhou
Journal:  Acta Trop       Date:  2013-07-29       Impact factor: 3.112

6.  The association between tropical cyclones and dengue fever in the Pearl River Delta, China during 2013-2018: A time-stratified case-crossover study.

Authors:  Chuanxi Li; Qi Zhao; Zhe Zhao; Qiyong Liu; Wei Ma
Journal:  PLoS Negl Trop Dis       Date:  2021-09-09

7.  Time series analysis of dengue fever and weather in Guangzhou, China.

Authors:  Liang Lu; Hualiang Lin; Linwei Tian; Weizhong Yang; Jimin Sun; Qiyong Liu
Journal:  BMC Public Health       Date:  2009-10-27       Impact factor: 3.295

8.  The prevalence and endemic nature of dengue infections in Guangdong, South China: an epidemiological, serological, and etiological study from 2005-2011.

Authors:  Ru-Ning Guo; Jin-Yan Lin; Lin-Hui Li; Chang-Wen Ke; Jian-Feng He; Hao-Jie Zhong; Hui-Qiong Zhou; Zhi-Qiang Peng; Fen Yang; Wen-Jia Liang
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.